Johnson & Johnson vs Abbvie Inc.
JNJ vs ABBV — side-by-side comparison from reported financials. JNJ leads 8, ABBV leads 3 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | JNJ | ABBV |
|---|---|---|
| Price | $261.79 | $276.43 |
| Market cap | $631B | $488B |
| Revenue (TTM) | $97.9B | $64.4B |
| Revenue growth | +5.6% | +1.8% |
| Net margin | 21.5% | 9.8% |
| Free cash flow | $22.2B | $18.2B |
| Net cash (debt) | ($27.8B) | ($56.2B) |
| 1-year price return | +37.0% | +19.8% |
| P/E | 29.9 | 77.4 |
| P/E vs own history (cheap-side %) | 16% | 23% |
| Dividend yield | 2.00% | 2.45% |
| Return on equity | 26% | 96% |
| Altman Z-score | — | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 140,800 | 57,000 |
Full résumé-style profiles: JNJ CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.